ELMSFORD, N.Y.--(Business Wire)--
BioScrip, Inc. (Nasdaq: BIOS) announced today that it will host a
conference call at 10:00 a.m. ET on May 2, 2008, to discuss its first
quarter operating results for the period ended March 31, 2008.
BioScrip will issue a press release announcing the operating results
before the market open on May 2, 2008. Interested parties may
participate in the conference call by dialing 800-732-5617 (US), or
212-231-2901 (International), 5-10 minutes prior to the start of the
call. A replay of the conference call will be available from 12:00
p.m. ET on May 2, through 12:00 p.m. ET on May 8, by dialing
800-633-8284 (US), or 402-977-9140 (International), and entering
reservation #21381814. An audio webcast and archive of the conference
call will also be available under the investor relations section of
the BioScrip website, www.bioscrip.com.
About BioScrip, Inc.
BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty
pharmaceutical healthcare organization that partners with patients,
physicians, healthcare payors and pharmaceutical manufacturers to
provide access to medications and management solutions to optimize
outcomes for chronic and other complex healthcare conditions.
Forward Looking Statements
This press release may contain statements which constitute forward
looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, including statements regarding the
intent, belief or current expectations of the Company, its directors,
or its officers with respect to the future operating performance of
the Company and our success with respect to the integration and
consolidation. Investors are cautioned that any such forward looking
statements are not guarantees of future performance and involve risks
and uncertainties, and that actual results may differ materially from
those in the forward looking statements as a result of various
factors. Important factors that could cause such differences are
described in the Company's periodic filings with the Securities and
Exchange Commission.
BioScrip, Inc.
Craig Allison, 914-460-1636
Director, Corporate Communications
callison@BioScrip.com
Copyright Business Wire 2008
